BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 10480411)

  • 1. Prevention of osteoporosis after cardiac transplantation: a prospective, longitudinal, randomized, double-blind trial with calcitriol.
    Stempfle HU; Werner C; Echtler S; Wehr U; Rambeck WA; Siebert U; Uberfuhr P; Angermann CE; Theisen K; Gärtner R
    Transplantation; 1999 Aug; 68(4):523-30. PubMed ID: 10480411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of tacrolimus (FK506)-based immunosuppression on bone mineral density and bone turnover after cardiac transplantation: a prospective, longitudinal, randomized, double-blind trial with calcitriol.
    Stempfle HU; Werner C; Siebert U; Assum T; Wehr U; Rambeck WA; Meiser B; Theisen K; Gärtner R
    Transplantation; 2002 Feb; 73(4):547-52. PubMed ID: 11889427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of immunosuppression-induced hypogonadism on bone metabolism after heart transplantation].
    Stief J; Sohn HY; Alt A; Uberfuhr P; Theisen K; Stempfle HU
    Dtsch Med Wochenschr; 2004 Jul; 129(31-32):1674-8. PubMed ID: 15273918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of bone loss after heart transplantation with antiresorptive therapy: a pilot study.
    Shane E; Rodino MA; McMahon DJ; Addesso V; Staron RB; Seibel MJ; Mancini D; Michler RE; Lo SH
    J Heart Lung Transplant; 1998 Nov; 17(11):1089-96. PubMed ID: 9855448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of calcitriol on bone loss after cardiac or lung transplantation.
    Sambrook P; Henderson NK; Keogh A; MacDonald P; Glanville A; Spratt P; Bergin P; Ebeling P; Eisman J
    J Bone Miner Res; 2000 Sep; 15(9):1818-24. PubMed ID: 10977001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of bone loss and vertebral fractures in patients with chronic epilepsy--antiepileptic drug and osteoporosis prevention trial.
    Lazzari AA; Dussault PM; Thakore-James M; Gagnon D; Baker E; Davis SA; Houranieh AM
    Epilepsia; 2013 Nov; 54(11):1997-2004. PubMed ID: 24010637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss.
    Gallagher JC; Fowler SE; Detter JR; Sherman SS
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3618-28. PubMed ID: 11502787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of osteoporosis in heart transplant recipients: a comparison of calcitriol with calcitonin and pamidronate.
    Bianda T; Linka A; Junga G; Brunner H; Steinert H; Kiowski W; Schmid C
    Calcif Tissue Int; 2000 Aug; 67(2):116-21. PubMed ID: 10920215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with intermittent calcitriol and calcium reduces bone loss after renal transplantation.
    Torres A; García S; Gómez A; González A; Barrios Y; Concepción MT; Hernández D; García JJ; Checa MD; Lorenzo V; Salido E
    Kidney Int; 2004 Feb; 65(2):705-12. PubMed ID: 14717945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone loss and turnover after cardiac transplantation.
    Shane E; Rivas M; McMahon DJ; Staron RB; Silverberg SJ; Seibel MJ; Mancini D; Michler RE; Aaronson K; Addesso V; Lo SH
    J Clin Endocrinol Metab; 1997 May; 82(5):1497-506. PubMed ID: 9141540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of discontinuation of estrogen, calcitriol, and the combination of both on bone density and bone markers.
    Gallagher JC; Rapuri PB; Haynatzki G; Detter JR
    J Clin Endocrinol Metab; 2002 Nov; 87(11):4914-23. PubMed ID: 12414850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alendronate versus calcitriol for the prevention of bone loss after cardiac transplantation.
    Shane E; Addesso V; Namerow PB; McMahon DJ; Lo SH; Staron RB; Zucker M; Pardi S; Maybaum S; Mancini D
    N Engl J Med; 2004 Feb; 350(8):767-76. PubMed ID: 14973216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of calcium supplementation on bone loss and fractures in congestive heart failure.
    Frost RJ; Sonne C; Wehr U; Stempfle HU
    Eur J Endocrinol; 2007 Mar; 156(3):309-14. PubMed ID: 17322490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of calcitriol on bone mineral density in premenopausal Chinese women taking chronic steroid therapy. A randomized, double blind, placebo controlled study.
    Lambrinoudaki I; Chan DT; Lau CS; Wong RW; Yeung SS; Kung AW
    J Rheumatol; 2000 Jul; 27(7):1759-65. PubMed ID: 10914864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of alendronate on bone mineral density and bone metabolic markers in patients with liver transplantation.
    Atamaz F; Hepguler S; Akyildiz M; Karasu Z; Kilic M
    Osteoporos Int; 2006; 17(6):942-9. PubMed ID: 16550299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D analogs versus native vitamin D in preventing bone loss and osteoporosis-related fractures: a comparative meta-analysis.
    Richy F; Schacht E; Bruyere O; Ethgen O; Gourlay M; Reginster JY
    Calcif Tissue Int; 2005 Mar; 76(3):176-86. PubMed ID: 15692726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Supplementation with oral vitamin D3 and calcium during winter prevents seasonal bone loss: a randomized controlled open-label prospective trial.
    Meier C; Woitge HW; Witte K; Lemmer B; Seibel MJ
    J Bone Miner Res; 2004 Aug; 19(8):1221-30. PubMed ID: 15231008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 1-year randomized, double-blind, placebo-controlled study of intravenous ibandronate on bone loss following renal transplantation.
    Smerud KT; Dolgos S; Olsen IC; Åsberg A; Sagedal S; Reisæter AV; Midtvedt K; Pfeffer P; Ueland T; Godang K; Bollerslev J; Hartmann A
    Am J Transplant; 2012 Dec; 12(12):3316-25. PubMed ID: 22946930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and treatment of decreased bone density in renal transplant recipients: a randomized prospective trial of calcitriol versus alendronate.
    Jeffery JR; Leslie WD; Karpinski ME; Nickerson PW; Rush DN
    Transplantation; 2003 Nov; 76(10):1498-502. PubMed ID: 14657693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Better late than never? Experience with intravenous pamidronate treatment in patients with low bone mass or fractures following cardiac or liver transplantation.
    Dodidou P; Bruckner T; Hosch S; Haass M; Klar E; Sauer P; Ziegler R; Leidig-Bruckner G
    Osteoporos Int; 2003 Jan; 14(1):82-9. PubMed ID: 12577189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.